CDC: PCPs to Inform Families of Sickle Cell Trait in Newborns

Share this content:
CDC: PCPs to Inform Families of Sickle Cell Trait in Newborns
CDC: PCPs to Inform Families of Sickle Cell Trait in Newborns

(HealthDay News) -- Primary care providers should offer educational materials and provide genetic counseling to families when they receive positive results for sickle cell trait (SCT) at the time of newborn screening, according to a report published in the Dec. 12 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Jelili Ojodu, M.P.H., of the Association of Public Health Laboratories in Silver Spring, Md., and colleagues compiled data and released a report on the 2010 incidence of SCT in the United States.

The researchers found that, in 2010, the estimate for the total U.S. incidence of SCT was 15.5 cases per 1,000 births, ranging from 0.8 cases per 1,000 births in Montana to 34.1 cases per 1,000 births in Mississippi. By race only, the total U.S. incidence of SCT was 73.1 cases per 1,000 black births, 3.0 cases per 1,000 white births, and 2.2 cases per 1,000 Asian or Native Hawaiian or Other Pacific Islander births. By ethnicity only, the total U.S. incidence of SCT was 6.9 cases per 1,000 Hispanic births. SCT has been reported in every state and every racial/ethnic population. Primary care providers should offer educational materials and genetic counseling to families of newborns with positive results for SCT.

"The period immediately after newborn screening is ideal for primary care providers and genetic counselors to begin educating the families of identified persons with sickle cell trait about potential health complications and reproductive considerations," the authors write.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »